- Home
- MREO vs THCH Comparison
MREO vs THCH Comparison
Compare MREO & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | THCH |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 58.9M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MREO | THCH |
|---|---|---|
| Price | $0.26 | $2.10 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 4.3K |
| Earning Date | 05-11-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | $5,184.20 | N/A |
| Revenue Next Year | $55.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $1.69 |
| 52 Week High | $2.94 | $3.25 |
Technical Indicators
Market Signals| Indicator | MREO | THCH |
|---|---|---|
| Relative Strength Index (RSI) | 26.91 | 51.04 |
| Support Level | $0.20 | $2.01 |
| Resistance Level | $0.36 | $2.31 |
| Average True Range (ATR) | 0.03 | 0.17 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 9.29 | 64.52 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.